CD274 and cancer: For instance, Lee et al. and Hu et al. have shown that removal of aberrant N-linked glycosylation in human cancer cells increases the affinity of the tumorigenic membrane glycoprotein PDL-1 [35–37], an important tumor antigen that is targeted for cancer therapy [35].